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IDENTIFICATION OF A POLYMORPHIC PLASMODIUM VIVAX
MICROSATELLITE MARKER
JOHN C. GOMEZ, DAVID T. MCNAMARA, MOSES J. BOCKARIE, J. KEVIN BAIRD, JANE M. CARLTON, AND
PETER A. ZIMMERMAN
Abstract. Microsatellite markers derived from simple sequence repeats have been useful in studying a number of
human pathogens, including the human malaria parasite Plasmodium falciparum. Genetic markers for P. vivax would
likewise help elucidate the genetics and population characteristics of this other important human malaria parasite. We
have identified a locus in a P. vivax telomeric clone that contains simple sequence repeats. Primers were designed to
amplify this region using a two-step semi-nested polymerase chain reaction protocol. The primers did not amplify
template obtained from non-infected individuals, nor DNA from primates infected with the other human malaria
parasites (P. ovale, P. malariae, or P. falciparum). The marker was polymorphic in P. vivax-infected field isolates
obtained from Papua New Guinea, Indonesia and Guyana. This microsatellite marker may be useful in genetic and
epidemiologic studies of P. vivax malaria.
INTRODUCTION
Human malaria caused by Plasmodium vivax rarely kills
like P. falciparum, but it causes a debilitating febrile illness in
approximately 90 million people each year. The severe and
widespread morbidity associated with endemic P. vivax ma-
laria in Asia and the Americas exacts a heavy social and
economic cost.1 Malaria caused by P. vivax represents a sig-
nificant re-emerging disease threat, and resistance to avail-
able therapies may be a dominant factor driving that trend.2
Definitive evaluation of therapeutic efficacy requires the abil-
ity to distinguish natural reinfection and relapse from recru-
descence due to therapeutic interventions, as well as provide
an instrument for examining P. vivax population dynamics.
Simple sequence repeats are ubiquitous in eukaryotic ge-
nomes and have been used to generate microsatellite markers
for genetic studies of many organisms. Microsatellite loci are
often polymorphic due to differences in length of these simple
sequences. Simple sequences are abundant in the genome of
the malaria parasite P. falciparum, and genetic markers de-
rived from polymorphic microsatellite loci have been used to
map traits and to investigate parasite population genetics;3–5
limited P. vivax population studies have become possible
through identification in the merozoite surface protein 3 al-
pha locus.6 Anderson and others used 12 microsatellite mark-
ers to characterize P. falciparum in finger prick blood samples
obtained in Papua New Guinea and showed they could re-
producibly quantify multiple infections.7 In other studies, mi-
crosatellite genotyping of widely distributed parasite isolates
has revealed differences in parasite genetic diversity and
population differentiation between areas of high and low
transmission intensity,8 and more recently predictions regard-
ing the evolution and spread of polymorphism associated with
chloroquine resistance9 have been made.
Both P. vivax and P. falciparum possess 14 chromosomes;
P. vivax chromosomes appear to be significantly larger.10 The
A/T content of the P. vivax genome is estimated to be ap-
proximately 60%,11 which is considerably lower than the 81%
A/T content reported for P. falciparum.12 In comparative
studies, significant regions of gene synteny are observed be-
tween P. vivax and P. falciparum.13 The purpose of this study
was to identify polymorphic microsatellite loci in P. vivax, and
to use the polymorphic locus or loci to characterize field iso-
lates obtained from P. vivax-endemic regions in Southeast
Asia, Melanesia, and South America.
MATERIALS AND METHODS
Plasmodium vivax sequences were obtained from two
sources: 1) a 1.5-Mb telomeric YAC contig14 (GenBank ac-
cession number AL360354), and 2) 10,874 P. vivax genome
survey sequences (GSS) from mung bean nuclease−digested
genomic DNA libraries of the Salvador 1 and Belem P. vivax
strains.15 Simple sequence repeats were identified by Tandem
Repeat Finder16 analysis of the GSS database, and by
BLASTX analysis of the GSS database using the query terms
(TA)n, (TAA)n, (CA)n, or (CAA)n, (where n 8−13), and
by visual inspection of the entire YAC IVD10 sequence.
All study protocols were reviewed and approved by insti-
tutional review boards from all participating institutions. In-
formed consent was obtained from all human adult partici-
pants and from parents or legal guardians of minors. Blood
samples were obtained from P. vivax-infected individuals in
Indonesia and Guyana. Finger prick blood samples were ab-
sorbed onto Whatman (Clifton, NJ) filter paper and air-dried
(blood blots). DNA prepared from blood blots was extracted
as follows. A 3-mm2 square piece of blood-impregnated filter
paper was excised using a razor and transferred to a tube
containing approximately 50 L of methanol and incubated at
room temperature for 15 minutes. The methanol was re-
moved and the sample-impregnated filter paper was allowed
to air-dry completely. We then added 50 L of distilled water
to each sample, and heated the tube for 15 minutes at
95−100°C, vortexing occasionally during the incubation. Ad-
ditional blood samples were obtained as part of malaria field
studies in Papua New Guinea. Extraction of DNA from all
Papua New Guinean samples was performed using the
QIAamp 96 DNA blood kit (Qiagen, Valencia, CA).
Initial samples used to validate the specificity of the mic-
rosatellite described here were positive for P. vivax infection
by microscopic examination of blood smears and by polymer-
ase chain reaction (PCR) diagnosis targeting the small sub-
unit ribosomal RNA gene sequence.17 As negative controls,
we included DNA samples from uninfected individuals, and
from primate blood samples infected with the three other
human malaria parasites (P. falciparum, P. ovale, and P. ma-
lariae). A nested or semi-nested PCR strategy was used to
amplify template DNA since levels of parasite infection are
variable and often low. With this strategy, an aliquot of a nest
1 reaction was used as template in a subsequent nest 2 PCR
targeting a smaller sequence contained within the first ampli-
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con. In the semi-nested strategy used here, the primers used
to amplify the YAC IVD10 microsatellite were as follows:
for nest1, 5-CAGAGAATTCTGTCCAATCATC-3
(N1upstream) and 5-CAGTAATCTAACATGGCTATT
AG-3 (N1downstream); and for nest 2, 5-Cy5GTAA
AAATTCGAAACATC-3 (N2upstream) and 5-TT
TTATTCACAGTAAAGTGC-3 (N2downstream). Geno-
mic DNA (3 L/sample) was combined with 1× PCR buffer
(67 mM Tris-HCl, pH 8.8, 6.7 mM MgSO4, 16.6 mM
NH4)2SO4, 10 mM 2-mercaptoethanol), 30 pmoles of each of
reverse and forward primers, 0.5 units of Taq DNA polymer-
ase, 200 M dNTP, and water (25-L reaction volume). Forty
cycles of 94°C for 30 seconds, 60°C for 30 seconds, and 72°C
for 30 seconds were completed for nest 1. For the nest 2
reaction of the nest 1 product, 3 L was added to a mixture
containing the appropriate nest 2 reagents and amplified by
25 cycles of a two-step PCR of 94°C for 30 seconds and 55°C
for one minute. Aliquots of the PCR products were subjected
to electrophoresis on a 6% polyacrylamide gel (7.7 M urea/
32% formamide). Fluorescence signal (Cy5) from the micro-
satellites was visualized using a Storm 860 (Molecular Dy-
namics, Sunnyvale, CA).
RESULTS
We identified a region (nucleotide positions 61123 to
61162) in the telomeric YAC clone IVD10 (GenBank Acces-
sion no. AL360354) that contained (AT)20. The microsatellite
is located within the second exon of the vir13 pseudogene.
Preliminary analyses suggested that the PCR products faith-
fully amplified from samples previously determined to be P.
vivax-infected and did not amplify from samples from unin-
fected North Americans or samples known to be infected with
other human Plasmodium species parasites. The DNA se-
quence analysis shown in Figure 1 confirmed that the ampli-
con was homologous to the reference sequence from IVD10.
Comparison of individual clones further suggested that this
sequence was polymorphic resulting from differences in the
number of AT repeats (n  8−20).
Results in Figure 2 provide examples of the microsatellite
polymorphism observed from five sequenced clones (lanes
1−5), negative controls from two uninfected North Americans
(lanes 6 and 7), P. falciparum, P. malariae, and P. ovale (lanes
8−10), and 13 P. vivax-infected individuals from Papua New
Guinea (lanes 11−23). The band positions for the cloned se-
quences corresponded as predicted from the DNA sequence
analysis. As indicated earlier in this report, we observed no
evidence of PCR amplification from the negative control
samples. The field isolates shown in Figure 2 exhibit allele size
variation from 8 to 17 repeats. Some samples appear to be
infected with more than one P. vivax strain, as shown by the
presence of two or more high signal intensity bands (Figure 2,
lanes 11, 13, and 15).
In a survey of 89 P. vivax-infected individuals from Papua
New Guinea, we observed allele size variation from 7 to 24
repeats. Of the 15 different allelic products observed at this
microsatellite locus (Table 1), the most frequent alleles from
this survey were 11 (17 of 89  19.1%) and 12 (27 of 89 
30.3%) AT repeats in length. At least four individuals showed
evidence of infection by more than one P. vivax strain. The
gene diversity (heterozygosity) for this microsatellite was cal-
culated18 to be 0.85.
DISCUSSION
Further attempts were made to determine if additional
polymorphic microsatellites could be amplified. Despite in
silico screening of 5 Mb (approximately 20% of the complete
genome from the P. vivax genome sequence data base; as-
sumes a genome size of 26 Mb) and identification of several
putative microsatellites, we were not able to confirm their
presence in laboratory stocks of P. vivax, nor in field isolates
by PCR amplification. This failure is likely due to several
factors, among them contamination with host DNA and simi-
larities across Plasmodium species’ genomes. Additional
strategies for identifying microsatellite sequences may be-
FIGURE 1. Sequence alignment of five Plasmodium vivax micro-
satellite (PvMS) alleles. Sequence alignments show the underlying
length differences in the AT repeat length responsible for microsat-
ellite mobility polymorphisms (an example is shown in Figure 2). -
nucleotide identity; x  deleted nucleotides. The microsatellite se-
quences shown were obtained from three different P. vivax strains
(Sal1, Thai 3, and Pv2). The nucleotide sequences of the polymorphic
P. vivax microsatellite sequences PvMS1.08, PvMS1.09, PvMS1.12,
PvMS1.14, and PvMS1.16, have been assigned the GenBank Acces-
sion numbers AY289756, AY289757, AY289758, AY289759, and
AY289760, respectively.
FIGURE 2. Plasmodium vivax microsatellite polymorphism from
Papua New Guinean field samples. Lanes 1−5 illustrate P. vivax mi-
crosatellite mobility polymorphisms for alleles identified in Figure 1.
Polymerase chain reaction (PCR) amplification of negative control
samples are shown in lanes 6−10 .The PCRs were performed using
genomic DNA from P. falciparum (lane 6), P. malariae (lane 7), P.
ovale (lane 8), and two human volunteers (lanes 9 and 10) who had
not visited malaria-endemic regions. Lanes 11−23 illustrate microsat-
ellite mobility polymorphisms observed in 13 P. vivax-infected indi-
viduals from East Sepik Province, Papua NewGuinea. Mixed P. vivax
strain infections were suggested by multiple banding patterns in
which secondary bands were at least 50% of the intensity of the
strongest band. Examples of mixed P. vivax strain infections were
observed in lanes 11, 13, and 15.
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come clearer as the P. vivax genome sequencing project nears
completion.11
In summary, the identification of additional polymorphic
markers should enable investigators to address questions re-
garding the epidemiology and population structure of P.
vivax, and host-parasite interactions. Moreover, the markers
should improve assessments of therapeutic efficacy and ulti-
mately contribute to development of more effective treat-
ments needed for achieving control of a worsening trend in
endemic malaria transmission.19
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Plasmodium vivax microsatel l i te al le l ic polymorphism
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